Primer la Llar program
OtherHousing First model: permanent housing without previous requirements such as abstinence, sobriety or compliance with treatment.
NCT Number: NCT03622151
The main goal is to evaluate the impact of the Primer La Llar housing program for the homeless population on the mental health of the participants.
The hypothesis is that the housing program, which follows Housing first model, for the homeless population has a positive impact on the mental health of the participants, compared to the group that does not receive the intervention -treatment as usual group (meaning the "positive impact" a lower score on the symptomatology scales and lower toxic intake in the group receiving the intervention).
Looking for future studies?
Notify Me18 year–72 year
All sexes
Interventional
Not applicable
The specific objectives are:
Identify the socio-demographic and clinical characteristics of the participants.
Compare the severity of psychiatric symptoms and improvement among the participants in the intervention group and the control group (depressive, anxious, psychotic or manic symptomatology, depending on the case).
Compare the consumption of alcohol and drugs among the participants of both groups.
Compare the basic daily life skills among the participants in both groups, as well as the improvement of them in the experimental group.
Compare the use of services and between the participants of the intervention group and the control group.
Intervention group receives entry to the program (which means individual and permanent housing without previous requirements such as abstinence, compliance with treatment or sobriety.
Control group receives treatment as usual, as they are users of homeless population network of Barcelona.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Housing First model: permanent housing without previous requirements such as abstinence, sobriety or compliance with treatment.
Time frame: Up to 21 months
PANSS scale (Positive And Negative Syndrome Scale). Subscales: 1. PANSS-P-Positive (7 ítems): range 7-49 (minimum and maximum scores) 2. PANSS-N-Negative (7 ítems). Range: 7-49. 3. PANSS-PG- general psychopathology (16 ítems). Range: 16-112. Higher values represent a worse outcome. Subscales are summed to compute a total score.
Time frame: Up to 21 months
HARS scale (Hamilton Anxiety Rating Scale). Total range:0-56. Higher values represent a worse outcome.
Time frame: Up to 21 months.
HDRS scale (Hamilton Depression Rating Scale). Total range: 0-52. Higher values represent a worse outcome.
Time frame: Up to 21 months
To see if there are increases or decreases in use of general and specific health services; questionnaire on use of services.
Time frame: Up to 21 months
BELS scale (Basic everyday living skills). Range subscales:
self-care (0-40) domestic skills (0-28) community skills (0-16) and activity and social relations (0-20). Higher value reports better outcome. Subescales are summed to compute a total score.
Time frame: Up to 21 months
Number of participants from each country, average age, number of men and women, number of participants with a problem of substance abuse or mental health, etc.
Assessed by a questionnaire about clinical and socio-demographic items.
Time frame: Up to 21 months
Changes in alcohol abuse in both groups Audit test (0-40). Higher value reports worse outcome.
Time frame: Up to 21 months
Increase or decrease on drug abuse in both groups
Parc Sanitari Sant Joan de Déu
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04543097
Absence, Behavior
Newcastle-under-Lyme, United Kingdom
View Trial DetailsNCT05753423
Behavior, Mental Disorders
Cairo, Egypt
View Trial DetailsNCT06213194
Autism Spectrum Disorder, Autism or Autistic Traits
Istanbul, Basaksehir, Turkey (Türkiye)
View Trial DetailsNCT05282173
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Cape Town, Western Cape, South Africa
View Trial Details